IMPORTANT SAFETY INFORMATION about Cabaser – (Issued 13th September 2008)

Pfizer Australia has informed us about important safety changes to Cabaser® (cabergoline) in the treatment of Parkinson’s disease and the availability of one of the strengths.

These changes will come into effect on 1st November 2008.

Menu